Influence of the activities and physical condition has on the cytokine expression by electrical stimulation

Influence of the activities and physical condition has on the cytokine expression by electrical stimulation - Influence of the activities and physical condition has on the cytokine expression by electrical stimulation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000026334

Enrollment

Registered

2018-04-01

Start date

2016-04-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

Muscle electrical stimulation

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: To participate in this research, those who can acquire document consent by their free will with sufficient understanding after receiving sufficient explanation and for healthy volunteers aged 20 to 26 when acquiring consent.

Exclusion criteria

Exclusion criteria: Those who have disorders that are thought to affect metabolism such as heart failure, diabetes, etc., those who are at risk for intervention such as epilepsy, others who have judged that it is inappropriate by the research director, the research sharing person.

Design outcomes

Primary

Measure	Time frame
Expression level of 40 types of cytokines by muscle electrical stimulation: Eotaxin, Eotaxin-2, GCSF, GM-CSF, ICAM-1, IFN-gamma, I-309, IL-1alpha, IL-1beta, IL-2, IL-3, IL-4, IL-6, IL-6sR, IL-7, IL-8, IL-10, IL-11, IL-12p40, IL-12p70, IL-13, IL-15, IL-16, IL-17, IP-10, MCP-1, MCP-2, M-CSF, MIG, MIP-1alpha, MIP-1beta, MIP-1delta, RANTES, TGF-beta1, TNF-alpha, TNF-beta, sTNF RI, sTNF-RII, PDGF-BB, TIMP-2	—

Measure

Time frame

Expression level of 40 types of cytokines by muscle electrical stimulation: Eotaxin, Eotaxin-2, GCSF, GM-CSF, ICAM-1, IFN-gamma, I-309, IL-1alpha, IL-1beta, IL-2, IL-3, IL-4, IL-6, IL-6sR, IL-7, IL-8, IL-10, IL-11, IL-12p40, IL-12p70, IL-13, IL-15, IL-16, IL-17, IP-10, MCP-1, MCP-2, M-CSF, MIG, MIP-1alpha, MIP-1beta, MIP-1delta, RANTES, TGF-beta1, TNF-alpha, TNF-beta, sTNF RI, sTNF-RII, PDGF-BB, TIMP-2

—

Secondary

Measure	Time frame
knee extension muscle strength, oxygen uptake at rest, peak oxygen uptake	—

Countries

Japan

Contacts

Public ContactTakahiro Momota

Fujita Health University School of Health Science

momo@fujita-hu.ac.jp+81-562-93-9000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026